News › Industry News, News

Crown Laboratories Now Operates Under the Name Revance

May 2, 2025

Crown Laboratories, Inc. has announced that it will operate under the name Revance, a name that best represents the newly combined company mission to revolutionize the aesthetics and skincare industry through science-based, innovative products.

This change marks a significant milestone in the company’s strategic transformation following its recent acquisition of Revance Therapeutics, Inc., a biotechnology company known for its cutting-edge innovation in aesthetics and therapeutics, which joins Crown’s deep roots in science-driven brands for skin health and rejuvenation.

About Revance
Revance is a fast-growing global aesthetics and skincare company focused on providing innovative aesthetics and market-leading skincare offerings throughout every stage of life. With a differentiated portfolio of products spanning 60 countries, Revance meets the evolving needs of patients and consumers worldwide through continued innovation and commercialization of new products and treatments.

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Compounded Tirzepatide, NAD+ Injections Recalled Nationwide Over Sterility Concerns
    • Meliora Consulting Becomes Silver Vendor Affiliate with the American Med Spa Association
    • FDA Sends Peptide ‘Interim Access Policy’ to White House for Review
    • New ACOG Menopause Guidelines Expand Hormone Therapy and Symptom Treatment Recommendations
    • Galderma to Acquire ZO Skin Health for $1.5 Billion
Advertisement